Bristol Myers Squibb has announced grants totaling $11 million in support of fifty-six organizations working to advance health equity nationwide.
Part of a $150 million commitment to advance diversity, inclusion, and health equity announced by the company in August, the grants will support efforts to boost diversity among clinical researchers, improve access to high-quality care, and increase disease awareness and education in racially diverse and medically underserved communities. Recipients are working in areas such as oncology, hematology, immunology, and cardiovascular disease and include Tulane University, the American Society of Gene & Cell Therapy, Breastcancer.org, Grange Advocacy, the Lupus Research Alliance, the United Spinal Association, and the Trevor Project.
"We are realizing our vision to transform patients' lives through science as we build upon our company's strong foundation of addressing global health disparities to become one of the world's most inclusive biopharma companies," said Adam Lenkowsky, senior vice president and general manager of U.S. commercial at Bristol Myers Squibb. "We understand that the need has never been more urgent, and we have made it a priority to focus our capabilities and resources to eliminate the barriers to accessing high-quality care that exist for underserved and vulnerable populations."